3186 results for «3577»
3186 results
Facilitating coronary access after TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
What are the challenges in coronary access after TAVI and what techniques may be used to facilitate it? Join this session to learn the answers to that question, as well as gaining insight into how to optimize the coronary access in the index procedure.
Unraveling aortic valve complexities: grading challenges, intervention decisions, and advanced imaging techniques
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
Explore the complexities of aortic valve disorders in this PCR Imaging Valves Madrid 2024 session, covering topics from grading challenges to intervention decisions in both asymptomatic and symptomatic patients, and learn more about advanced imaging techniques for quantifying aortic regurgitation severity and navigating treatment choices for...
The aortic regurgitation problem: an imaging and practical perspective
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
In this session, discover strategies to address biases in aortic regurgitation, influenced by factors like etiology, natural history, surgical risk, age, and gender, and explore an imaging-centric approach to better quantify aortic regurgitation and comprehend its relationship with left ventricular remodeling and outcomes. Anticipate forthcoming guidelines...
TAVI essentials: anatomical factors, prosthesis selection, and complication management
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
Discover a comprehensive exploration of critical considerations in TAVI in this section. From anatomical factors guiding the choice between TAVI and SAVR to strategies for selecting the optimal TAVI prosthesis for individual patients, each topic offers essential insights. Gain valuable insights into navigating TAVI for bicuspid...
Comprehensive assessment of mitral valve disorders and treatment outcomes
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
This session offers a comprehensive exploration of mitral valve disorders, covering diagnosis and severity assessment from multiple perspectives. From morphology-based diagnosis to echocardiography and CMR assessments, gain insights into distinguishing between rheumatic and calcific mitral stenosis, evaluating outcomes post-TMVR and surgical repair, and assessing bioprosthetic and...
Optimizing case selection and procedure guidance in transcatheter mitral valve interventions
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
This session examines the critical aspect of case selection for various transcatheter mitral valve interventions, ranging from TEER in secondary mitral regurgitation to balloon valvotomy in mitral stenosis and transcatheter mitral valve replacement. It explores the intricacies of procedure planning and guidance for TEER, alongside methods...
Tricuspid valve disease: diagnosis and classification
03 Feb 2024 – From PCR Imaging Valves Madrid 2024
Discover, in this comprehensive 3rd episode of PCR Imaging Valves Madrid 2024, the nuances of diagnosing and grading tricuspid valve disease, including insights into normal and abnormal function post-repair or replacement, the pivotal role of imaging in valve quantification and device selection, strategies for assessing right ventricular...
Advanced imaging strategies in transcatheter tricuspid valve therapies
03 Feb 2024 – From PCR Imaging Valves Madrid 2024
In this PCR Imaging Valves Madrid 2024 session, discover the use of various imaging techniques in transcatheter tricuspid valve therapies, ranging from standard TEE screening to comprehensive intra-procedural assessments, facilitating optimal device selection, procedural success, and post-procedural monitoring.
Multivalvular disease: diagnostic challenges and treatment strategies for aortic and mitral valve disorders
03 Feb 2024 – From PCR Imaging Valves Madrid 2024
Addressing the complex diagnostic challenges in aortic stenosis and regurgitation, this session examines the timing of treatment initiation and the decision-making process when aortic valve disease coincides with aortic pathology. It also explores the ongoing healthcare burden posed by mitral regurgitation and stenosis, emphasizing the importance...
TAVI for patients with concomitant coronary artery disease - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...
PCR Tokyo Valves 2024 Welcome Ceremony
17 Feb 2024 – From PCR Tokyo Valves 2024
After a brief overview of the Course's history and the success of the PCR Family's various Courses, join the Course Directors as they unveil the new venue for the 2024 edition, introduce the team, and reveal the schedule for three intense days featuring a diverse and...
Selection of the 2024 best clinical cases
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the most outstanding clinical cases from PCR Tokyo Valves 2024, including a nightmare case with bicuspid aortic valve, pharmaco-invasive management of mechanical valve thrombus with cardiogenic shock, and a TAVR-in-TAVR challenge.
Rapid-fire - Tricuspid valve interventions in various situations
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore a diverse range of tricuspid valve interventions through various rapid-fire case studies. Learn about a successful TEER of torrential pentacuspid tricuspid regurgitation, gain insight into a percutaneous transcatheter balloon valvuloplasty as a bridge therapy for bioprosthetic tricuspid stenosis, and more!
Selection of the 2024 best abstracts
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the most outstanding abstracts from PCR Tokyo Valves 2024, such as a study on the disparity in impact of bleeding after TAVI on long-term mortality between Asian and Nordic population, learning about two-year clinical outcomes of staged transcatheter mitral edge-to-edge repair after TAVR, and a...
Recorded case demonstration in TAVI and Mitral
17 Feb 2024 – From PCR Tokyo Valves 2024
This session of record case demonstrations aims to better understand daily clinical practice in TAVI and MitraClip, as well as helping to resolve daily clinical questions in structural heart disease interventions. [In Japanese]
TAVI optimisation
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this series of slides to enhance your understanding of TAVI optimisation through selected studies for PCR Tokyo Valves 2024. Learn about the prognostic value of right ventricle dysfunction after TAVR, explore a risk model in dialysis patients following TAVR, and explore the impact of age...
TEER for primary mitral regurgitation
18 Feb 2024 – From PCR Tokyo Valves 2024
What are the current indications and future perspectives of using TEER for primary mitral regurgitation? Join this session if you want to gain insight into anatomical evaluation before TEER, learn the procedural strategy for complex primary mitral regurgitation, and explore the specific features of both MitraClip...
Structural heart disease care: innovations, teamwork, and patient focus
17 Feb 2024 – From PCR Tokyo Valves 2024
Delivered in Japanese, this session highlights the latest advances in structural heart disease treatment and diagnostics. Learn to understand effective interprofessional collaboration and find out more about patient-centered care excellence!
Valve-in-Valve
17 Feb 2024 – From PCR Tokyo Valves 2024
Discover various compelling cases of valve-in-valve interventions in this session: such as TAVI for a structural valve deterioration with winding snake-like aorta, the uses of tomography-fluoroscopy fusion imaging in bioprosthetic aortic valve cracking, and more!
Challenging situations in mitral valve interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
This selection of cases showcases a number of challenging situations in mitral valve interventions and how best to resolve them. Among such complications are a severe afterload mismatch following M-TEER in functional mitral regurgitation, a detached clip in the left atrium, and more.